SHL Telemedicine and Mayo Clinic enter agreement for use of SmartHeart™ technology across different platforms
Tel Aviv / Zurich, 30 August 2021 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), today announced that it has entered into an Agreement with Mayo Clinic, according to which Mayo Clinic will purchase SHL’s SmartHeartTM 12 Lead ECG unit and technology for the delivery of ECGs and related services, where Mayo Clinic will implement the SmartHeartTM for use in its clinical and patient care protocols.
